Trump’s transition team is said to be considering Jim O’Neill, a managing director of Peter Thiel’s Mithril Capital, as the new chief of the U.S. Food and Drug Administration. Bloombergfirst reported the news yesterday.

Some are optimistic about the pick (O’Neill has advocated for somewhat controversial ways for FDA to approve drugs faster); others have pointed to O’Neill’s lack of experience as he doesn’t have a medical background. Here are some of the top tweets:

My twitter feed is totally freaking out about the possibility of Jim O’Neill heading #fda. And you all thought the Cures bill could be scary